Atul pathak (14 resultados)

- Tapa blanda
Librería: AHA-BUCH GmbH, Einbeck, AlemaniaAHA-BUCH GmbH
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 30,62
Envío por EUR 35,00Se envía de Alemania a Estados Unidos de AmericaCantidad disponible: 2 disponibles
Taschenbuch. Condición: Neu. Neuware - MILLION DOLLAR FRANCHISESA franchise that cannot run without you is not a business. It is a job with a franchise fee attached.Most franchise owners plateau at one location and a full calendar. They are busy, profitable enough, and completely essential to the operation, which is exactly why it will never be worth what they hope.The owners who reach seven figures are rarely working harder than everyone else. They are building something different: repeatable unit economics, a management layer, and earnings that survive their absence. That is what a buyer pays for. That is what this book teaches.Million Dollar Franchises is the second half of the journey, written for owners who already hold the keys.Inside: - Why revenue is vanity and enterprise value is wealth, and how to manage for the second one- The unit economics that make a seven figure business mathematically possible, and the ones that never will- The four routes to scale: more units, better units, more brands, and acquisition- How to value a franchise business the way a buyer will one day value yours- Opening new versus buying existing, and when the right move is simply to wait- Buying struggling and distressed units at a discount, and turning them around- Your first 100 days as the owner of a business you just acquired- The owner to CEO transition, and the management team that makes it hold- Centralization, shared services, and the operating system behind multi unit growth- Smart leverage, debt service, and where the next dollar of profit should go- The risks that quietly destroy franchise wealth, from owner dependence to territory erosion- What AI and automation change for the franchise owner over the next decade- Building to sell: the seven figure exit playbook, and the legacy that follows itWho this book is forSingle unit owners ready for a second location. Multi unit operators caught between growth and burnout. Buyers evaluating an existing franchise business. Owners with an exit somewhere on the horizon who intend to arrive at it with the highest multiple they can earn.Written by Atul Pathak, senior franchise consultant and business ownership advisor, who has spent twenty years advising buyers, operators, and investors on selection, financing, expansion, and exit. He is also the author of Don't Buy That Franchise (Until You Read This), the companion volume for anyone still choosing their first franchise.Revenue is vanity. Enterprise value is wealth. Build the business a buyer would want, and you stop owning a job and start owning an asset.Educational content only. No earnings claim, promise, or guarantee is made or implied. Not legal, financial, or investment advice. Consult qualified professionals before any acquisition, expansion, or sale.…

- Tapa blanda
- Impresión bajo demanda
Librería: California Books, Miami, FL, Estados Unidos de AmericaCalifornia Books
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 19,25
Gastos de envío gratisSe envía dentro de Estados Unidos de AmericaCantidad disponible: Más de 20 disponibles
Condición: New. Print on Demand.

- Tapa blanda
- Impresión bajo demanda
Librería: PBShop.store US, Wood Dale, IL, Estados Unidos de AmericaPBShop.store US
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 19,51
Gastos de envío gratisSe envía dentro de Estados Unidos de AmericaCantidad disponible: Más de 20 disponibles
PAP. Condición: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

- Tapa blanda
- Impresión bajo demanda
Librería: Grand Eagle Retail, Bensenville, IL, Estados Unidos de AmericaGrand Eagle Retail
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 19,73
Gastos de envío gratisSe envía dentro de Estados Unidos de AmericaCantidad disponible: 1 disponible
Paperback. Condición: new. Paperback. MILLION DOLLAR FRANCHISESA franchise that cannot run without you is not a business. It is a job with a franchise fee attached.Most franchise owners plateau at one location and a full calendar. They are busy, profitable enough, and completely essential to the operation, which is exactly why it will never be worth what they hope.The owners who reach seven figures are rarely working harder than everyone else. They are building something different: repeatable unit economics, a management layer, and earnings that survive their absence. That is what a buyer pays for. That is what this book teaches.Million Dollar Franchises is the second half of the journey, written for owners who already hold the keys.Inside: Why revenue is vanity and enterprise value is wealth, and how to manage for the second oneThe unit economics that make a seven figure business mathematically possible, and the ones that never willThe four routes to scale: more units, better units, more brands, and acquisitionHow to value a franchise business the way a buyer will one day value yoursOpening new versus buying existing, and when the right move is simply to waitBuying struggling and distressed units at a discount, and turning them aroundYour first 100 days as the owner of a business you just acquiredThe owner to CEO transition, and the management team that makes it holdCentralization, shared services, and the operating system behind multi unit growthSmart leverage, debt service, and where the next dollar of profit should goThe risks that quietly destroy franchise wealth, from owner dependence to territory erosionWhat AI and automation change for the franchise owner over the next decadeBuilding to sell: the seven figure exit playbook, and the legacy that follows itWho this book is forSingle unit owners ready for a second location. Multi unit operators caught between growth and burnout. Buyers evaluating an existing franchise business. Owners with an exit somewhere on the horizon who intend to arrive at it with the highest multiple they can earn.Written by Atul Pathak, senior franchise consultant and business ownership advisor, who has spent twenty years advising buyers, operators, and investors on selection, financing, expansion, and exit. He is also the author of Don't Buy That Franchise (Until You Read This), the companion volume for anyone still choosing their first franchise.Revenue is vanity. Enterprise value is wealth. Build the business a buyer would want, and you stop owning a job and start owning an asset.Educational content only. No earnings claim, promise, or guarantee is made or implied. Not legal, financial, or investment advice. Consult qualified professionals before any acquisition, expansion, or sale. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.…

Idioma: Inglés
Editorial: VDM Verlag Dr. Mueller Aktiengesellschaft & Co. KG, 2011
- Tapa blanda
Librería: Books Puddle, Woodside, NY, Estados Unidos de AmericaBooks Puddle
Contactar con el vendedorVendedor de 4 estrellasCondición: Nuevo
EUR 96,08
Envío por EUR 3,55Se envía dentro de Estados Unidos de AmericaCantidad disponible: 4 disponibles
Condición: New. pp. 156.

- Tapa blanda
- Impresión bajo demanda
Librería: PBShop.store UK, Fairford, GLOS, Reino UnidoPBShop.store UK
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 17,73
Envío por EUR 4,96Se envía de Reino Unido a Estados Unidos de AmericaCantidad disponible: Más de 20 disponibles
PAP. Condición: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

- Tapa blanda
Librería: preigu, Osnabrück, Alemaniapreigu
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 51,10
Envío por EUR 70,00Se envía de Alemania a Estados Unidos de AmericaCantidad disponible: 5 disponibles
Taschenbuch. Condición: Neu. Cationic Polymers based Non-viral Gene Carriers | Pharmaceutical Applications of Nano-vectors in Transfection Technology | Atul Pathak (u. a.) | Taschenbuch | 156 S. | Englisch | 2011 | LAP LAMBERT Academic Publishing | EAN 9783843376198 | Verantwortliche Person für die EU: BoD - Books on Demand, In de Tarpen 42, 22848 Norderstedt, info[at]bod[dot]de | Anbieter: preigu.…

- Tapa blanda
- Impresión bajo demanda
Librería: CitiRetail, Stevenage, Reino UnidoCitiRetail
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 22,09
Envío por EUR 44,12Se envía de Reino Unido a Estados Unidos de AmericaCantidad disponible: 1 disponible
Paperback. Condición: new. Paperback. MILLION DOLLAR FRANCHISESA franchise that cannot run without you is not a business. It is a job with a franchise fee attached.Most franchise owners plateau at one location and a full calendar. They are busy, profitable enough, and completely essential to the operation, which is exactly why it will never be worth what they hope.The owners who reach seven figures are rarely working harder than everyone else. They are building something different: repeatable unit economics, a management layer, and earnings that survive their absence. That is what a buyer pays for. That is what this book teaches.Million Dollar Franchises is the second half of the journey, written for owners who already hold the keys.Inside: Why revenue is vanity and enterprise value is wealth, and how to manage for the second oneThe unit economics that make a seven figure business mathematically possible, and the ones that never willThe four routes to scale: more units, better units, more brands, and acquisitionHow to value a franchise business the way a buyer will one day value yoursOpening new versus buying existing, and when the right move is simply to waitBuying struggling and distressed units at a discount, and turning them aroundYour first 100 days as the owner of a business you just acquiredThe owner to CEO transition, and the management team that makes it holdCentralization, shared services, and the operating system behind multi unit growthSmart leverage, debt service, and where the next dollar of profit should goThe risks that quietly destroy franchise wealth, from owner dependence to territory erosionWhat AI and automation change for the franchise owner over the next decadeBuilding to sell: the seven figure exit playbook, and the legacy that follows itWho this book is forSingle unit owners ready for a second location. Multi unit operators caught between growth and burnout. Buyers evaluating an existing franchise business. Owners with an exit somewhere on the horizon who intend to arrive at it with the highest multiple they can earn.Written by Atul Pathak, senior franchise consultant and business ownership advisor, who has spent twenty years advising buyers, operators, and investors on selection, financing, expansion, and exit. He is also the author of Don't Buy That Franchise (Until You Read This), the companion volume for anyone still choosing their first franchise.Revenue is vanity. Enterprise value is wealth. Build the business a buyer would want, and you stop owning a job and start owning an asset.Educational content only. No earnings claim, promise, or guarantee is made or implied. Not legal, financial, or investment advice. Consult qualified professionals before any acquisition, expansion, or sale. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.…

- Tapa blanda
- Impresión bajo demanda
Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, AlemaniaBuchWeltWeit Ludwig Meier e.K.
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 59,00
Envío por EUR 23,00Se envía de Alemania a Estados Unidos de AmericaCantidad disponible: 2 disponibles
Taschenbuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Nucleic acids-based next generation biopharmaceuticals (i.e., oligonucleotides, siRNA) are potential therapeutic agents have ability to cope with various incurable diseases. However, several biological barriers present a challenge for efficient gene delivery. Inception of nanotechnology now offer numerous non-viral vectors that have been fabricated and found capable of transmitting the biopharmaceuticals into the cell and even into specific subcellular compartments like mitochondria. This book illustrates novel chemically modified polyallylamine and polyethylenimine based nano- vectors for enhanced gene delivery. Modification of these polymers using imidazolyl and polysaccharides such as hyaluronic acid, chondroitin sulfate and heparin not only improve cytotoxicity index but also provides site-specificity for cell-type specific gene delivery. Incorporation of targeting moiety minimizes the chance of potential adverse effects and also reduces the amount the amount of dose required to achieve desired therapeutic effects. Recent developments in formulation of efficient drug carriers showed potential to develop gene therapy again diseases like cancer. 156 pp. Englisch.…

- Tapa blanda
- Impresión bajo demanda
Librería: AHA-BUCH GmbH, Einbeck, AlemaniaAHA-BUCH GmbH
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 59,00
Envío por EUR 35,00Se envía de Alemania a Estados Unidos de AmericaCantidad disponible: 1 disponible
Taschenbuch. Condición: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Nucleic acids-based next generation biopharmaceuticals (i.e., oligonucleotides, siRNA) are potential therapeutic agents have ability to cope with various incurable diseases. However, several biological barriers present a challenge for efficient gene delivery. Inception of nanotechnology now offer numerous non-viral vectors that have been fabricated and found capable of transmitting the biopharmaceuticals into the cell and even into specific subcellular compartments like mitochondria. This book illustrates novel chemically modified polyallylamine and polyethylenimine based nano- vectors for enhanced gene delivery. Modification of these polymers using imidazolyl and polysaccharides such as hyaluronic acid, chondroitin sulfate and heparin not only improve cytotoxicity index but also provides site-specificity for cell-type specific gene delivery. Incorporation of targeting moiety minimizes the chance of potential adverse effects and also reduces the amount the amount of dose required to achieve desired therapeutic effects. Recent developments in formulation of efficient drug carriers showed potential to develop gene therapy again diseases like cancer.…

- Tapa blanda
- Impresión bajo demanda
Librería: moluna, Greven, Alemaniamoluna
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 48,50
Envío por EUR 48,99Se envía de Alemania a Estados Unidos de AmericaCantidad disponible: Más de 20 disponibles
Condición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Pathak AtulDr. Atul Pathak is a Research Fellow at Immune Disease Institute, Program and Cellular and Molecular Medicine at Children Hospital, Harvard Medical School, Boston, USA. He earned his Ph.D. in Pharmaceutical Science. D. …

Idioma: Inglés
Editorial: VDM Verlag Dr. Mueller Aktiengesellschaft & Co. KG, 2011
- Tapa blanda
- Impresión bajo demanda
Librería: Majestic Books, Hounslow, Reino UnidoMajestic Books
Contactar con el vendedorVendedor de 4 estrellasCondición: Nuevo
EUR 98,03
Envío por EUR 7,75Se envía de Reino Unido a Estados Unidos de AmericaCantidad disponible: 4 disponibles
Condición: New. Print on Demand pp. 156 2:B&W 6 x 9 in or 229 x 152 mm Perfect Bound on Creme w/Gloss Lam.

Idioma: Inglés
Editorial: VDM Verlag Dr. Mueller Aktiengesellschaft & Co. KG, 2011
- Tapa blanda
- Impresión bajo demanda
Librería: Biblios, frankfurt am main, HESSE, AlemaniaBiblios
Contactar con el vendedorVendedor de 4 estrellasCondición: Nuevo
EUR 98,88
Envío por EUR 9,95Se envía de Alemania a Estados Unidos de AmericaCantidad disponible: 4 disponibles
Condición: New. PRINT ON DEMAND pp. 156.

- Tapa blanda
- Impresión bajo demanda
Librería: buchversandmimpf2000, Emtmannsberg, BAYE, Alemaniabuchversandmimpf2000
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 59,00
Envío por EUR 60,00Se envía de Alemania a Estados Unidos de AmericaCantidad disponible: 1 disponible
Taschenbuch. Condición: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Nucleic acids-based next generation biopharmaceuticals (i.e., oligonucleotides, siRNA) are potential therapeutic agents have ability to cope with various incurable diseases. However, several biological barriers present a challenge for efficient gene delivery. Inception of nanotechnology now offer numerous non-viral vectors that have been fabricated and found capable of transmitting the biopharmaceuticals into the cell and even into specific subcellular compartments like mitochondria. This book illustrates novel chemically modified polyallylamine and polyethylenimine based nano- vectors for enhanced gene delivery. Modification of these polymers using imidazolyl and polysaccharides such as hyaluronic acid, chondroitin sulfate and heparin not only improve cytotoxicity index but also provides site-specificity for cell-type specific gene delivery. Incorporation of targeting moiety minimizes the chance of potential adverse effects and also reduces the amount the amount of dose required to achieve desired therapeutic effects. Recent developments in formulation of efficient drug carriers showed potential to develop gene therapy again diseases like cancer.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 156 pp. Englisch.…